https://adisinsight.springer.com/drugs/800052752?error=cookies_not_supported&code=93b501e5-518d-4647-8c10-3858564dc902
Recaticimab - Jiangsu Hengrui Medicine Co. - AdisInsight
Recaticimab (formerly SHR 1209), an anti-proprotein convertase subtilisin/kexin9 (PCSK9) monoclonal antibody is being developed by Jiangsu HengRui Medicine Co.
jiangsumedicinecoadisinsight
https://pharma.economictimes.indiatimes.com/news/financial-performance/chinas-top-drugmaker-hengrui-profit-in-line-with-expectations-in-first-quarter-of-2026/130438225
Hengrui Pharmaceuticals Reports Strong Q1 2026 Profit Amidst Drug Coverage Growth, ETPharma
Jiangsu Hengrui Pharmaceuticals, China's largest drugmaker, sees Q1 2026 net profit rise by 21.8% to 2.3 billion yuan as drug coverage expands under national...
https://www.hengruiprotect.com/
Flame Retardant Fabric, Cut Proof Fabric, Insulating Fabric - Hengrui
Hengrui is specialized in the production of functional protective fabrics, including aramid fabric, Kevlar fabric, aramid yarn, high temperature resistant
flame retardant fabriccutproofinsulating